Maria K. Lehtinen

Publications

1. Choroid plexus inflammation in bipolar disorder. Brain Behav Immun. 2026 Apr 12; 136:106598. View Abstract
2. The choroid plexus: both a gatekeeper and a conductor of neuroimmune communication. J Immunol. 2026 Mar 25; 215(S3). View Abstract
3. A patient with a rare metabolic disease and myo-inositol administration leading to a new treatment for epilepsy. Mol Genet Metab. 2026 Jun; 148(2):109871. View Abstract
4. Temporal and cell-type specific SPAK-NKCC1 disruption following severe TBI in the developing gyrencephalic brain. Acta Neuropathol Commun. 2026 Feb 24; 14(1). View Abstract
5. Base barrier cells provide compartmentalization of choroid plexus, brain and CSF. Nat Neurosci. 2026 Mar; 29(3):551-566. View Abstract
6. Author Correction: Choroid plexus apocrine secretion shapes CSF proteome during mouse brain development. Nat Neurosci. 2026 Feb; 29(2):510. View Abstract
7. Author Correction: Choroid plexus apocrine secretion shapes CSF proteome during mouse brain development. Nat Neurosci. 2026 Jan; 29(1):246. View Abstract
8. Multi-modal choroid plexus pathology in aging and Alzheimer's disease. bioRxiv. 2026 Jan 01. View Abstract
9. Fluid-Niche and Microglial Signatures Prime Robust Intraventricular Macrophage Response to Blood During Brain Development. bioRxiv. 2025 Oct 02. View Abstract
10. Gestational psychedelic exposure disrupts brain development and offspring behavior in mice. bioRxiv. 2025 Sep 30. View Abstract
11. The use of synaptic extracellular myo-inositol to treat Developmental and Epileptic Encephalopathy. Ann Child Neurol Soc. 2025 Aug 25. View Abstract
12. Myocardial sympathetic distal axon loss in subjects with Lewy pathology in three autopsy cohorts. Acta Neuropathol. 2025 08 01; 150(1):11. View Abstract
13. Apocrine secretion by the choroid plexus. Fluids Barriers CNS. 2025 Jul 16; 22(1):75. View Abstract
14. Gene context drift identifies drug targets to mitigate cancer treatment resistance. Cancer Cell. 2025 Sep 08; 43(9):1608-1621.e9. View Abstract
15. Molecular hallmarks of hydrocephalus. Sci Transl Med. 2025 Jun 04; 17(801):eadq1810. View Abstract
16. Choroid plexus apocrine secretion shapes CSF proteome during mouse brain development. Nat Neurosci. 2025 Jul; 28(7):1446-1459. View Abstract
17. Protocol for the dissection, immunostaining, and imaging of whole-mount mouse choroid plexus. STAR Protoc. 2025 Mar 21; 6(1):103627. View Abstract
18. The choroid plexus: a command center for brain-body communication during inflammation. Curr Opin Immunol. 2025 Apr; 93:102540. View Abstract
19. Simultaneous, real-time tracking of many neuromodulatory signals with Multiplexed Optical Recording of Sensors on a micro-Endoscope. bioRxiv. 2025 Jan 30. View Abstract
20. Acute temporal, regional, and cell-type specific NKCC1 disruption following severe TBI in the developing gyrencephalic brain. bioRxiv. 2025 Jan 20. View Abstract
21. Choroid Plexus Pathophysiology. Annu Rev Pathol. 2025 01; 20(1):193-220. View Abstract
22. Choroid Plexus as a Mediator of CNS Inflammation in Multiple Sclerosis. Mult Scler. 2024 Dec; 30(5_suppl):19-23. View Abstract
23. Proinflammatory immune cells disrupt angiogenesis and promote germinal matrix hemorrhage in prenatal human brain. Nat Neurosci. 2024 Nov; 27(11):2115-2129. View Abstract
24. Profiling metabolome of mouse embryonic cerebrospinal fluid following maternal immune activation. J Biol Chem. 2024 10; 300(10):107749. View Abstract
25. The choroid plexus synergizes with immune cells during neuroinflammation. Cell. 2024 Sep 05; 187(18):4946-4963.e17. View Abstract
26. BioLuminescent OptoGenetics in the choroid plexus: integrated opto- and chemogenetic control in vivo. Neurophotonics. 2024 Apr; 11(2):024210. View Abstract
27. Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancers. Nat Commun. 2024 Jun 14; 15(1):5110. View Abstract
28. Antibodies expand the scope of angiotensin receptor pharmacology. Nat Chem Biol. 2024 Dec; 20(12):1577-1585. View Abstract
29. WNT signalling control by KDM5C during development affects cognition. Nature. 2024 03; 627(8004):594-603. View Abstract
30. Optimized Mass Spectrometry Detection of Thyroid Hormones and Polar Metabolites in Rodent Cerebrospinal Fluid. Metabolites. 2024 Jan 23; 14(2). View Abstract
31. Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancers. Res Sq. 2024 Jan 17. View Abstract
32. A choroid plexus apocrine secretion mechanism shapes CSF proteome and embryonic brain development. bioRxiv. 2024 Jan 16. View Abstract
33. Metabolomics of Mouse Embryonic CSF Following Maternal Immune Activation. bioRxiv. 2023 Dec 24. View Abstract
34. Optimized Mass Spectrometry Detection of Thyroid Hormones and Polar Metabolites in Rodent Cerebrospinal Fluid. bioRxiv. 2023 Dec 08. View Abstract
35. SCO-spondin knockout mice exhibit small brain ventricles and mild spine deformation. Fluids Barriers CNS. 2023 Dec 05; 20(1):89. View Abstract
36. Antibodies Expand the Scope of Angiotensin Receptor Pharmacology. bioRxiv. 2023 Aug 24. View Abstract
37. A collaboration between immune cells and the choroid plexus epithelium in brain inflammation. bioRxiv. 2023 Aug 08. View Abstract
38. Snapshot: Choroid plexus brain barrier. Cell. 2023 08 03; 186(16):3522-3522.e1. View Abstract
39. SCO-spondin knockout mice exhibit small brain ventricles and mild spine deformation. bioRxiv. 2023 Aug 03. View Abstract
40. LRP1 mediates leptin transport by coupling with the short-form leptin receptor in the choroid plexus. bioRxiv. 2023 Jul 03. View Abstract
41. Defining diurnal fluctuations in mouse choroid plexus and CSF at high molecular, spatial, and temporal resolution. Nat Commun. 2023 06 22; 14(1):3720. View Abstract
42. Age-appropriate potassium clearance from perinatal cerebrospinal fluid depends on choroid plexus NKCC1. Fluids Barriers CNS. 2023 Jun 16; 20(1):45. View Abstract
43. Choroid plexus-targeted NKCC1 overexpression to treat post-hemorrhagic hydrocephalus. Neuron. 2023 05 17; 111(10):1591-1608.e4. View Abstract
44. Outcomes of the 2019 hydrocephalus association workshop, "Driving common pathways: extending insights from posthemorrhagic hydrocephalus". Fluids Barriers CNS. 2023 Jan 13; 20(1):4. View Abstract
45. In utero intracerebroventricular delivery of adeno-associated viral vectors to target mouse choroid plexus and cerebrospinal fluid. STAR Protoc. 2023 03 17; 4(1):101975. View Abstract
46. The choroid plexus: a missing link in our understanding of brain development and function. Physiol Rev. 2023 01 01; 103(1):919-956. View Abstract
47. Choroid plexus-CSF-targeted antioxidant therapy protects the brain from toxicity of cancer chemotherapy. Neuron. 2022 10 19; 110(20):3288-3301.e8. View Abstract
48. Experimental approaches for manipulating choroid plexus epithelial cells. Fluids Barriers CNS. 2022 May 26; 19(1):36. View Abstract
49. Young cerebrospinal fluid improves memory in old mice. Nature. 2022 05; 605(7910):428-429. View Abstract
50. Disruption of GMNC-MCIDAS multiciliogenesis program is critical in choroid plexus carcinoma development. Cell Death Differ. 2022 08; 29(8):1596-1610. View Abstract
51. Correction: MEIS-WNT5A axis regulates development of fourth ventricle choroid plexus. Development. 2022 02 01; 149(3). View Abstract
52. Mitochondria in Early Forebrain Development: From Neurulation to Mid-Corticogenesis. Front Cell Dev Biol. 2021; 9:780207. View Abstract
53. Macrophages on the margin: choroid plexus immune responses. Trends Neurosci. 2021 11; 44(11):864-875. View Abstract
54. MEIS-WNT5A axis regulates development of fourth ventricle choroid plexus. Development. 2021 05 15; 148(10). View Abstract
55. A cellular and spatial map of the choroid plexus across brain ventricles and ages. Cell. 2021 05 27; 184(11):3056-3074.e21. View Abstract
56. Choroid plexus NKCC1 mediates cerebrospinal fluid clearance during mouse early postnatal development. Nat Commun. 2021 01 19; 12(1):447. View Abstract
57. Inflammation of the Embryonic Choroid Plexus Barrier following Maternal Immune Activation. Dev Cell. 2020 12 07; 55(5):617-628.e6. View Abstract
58. Tracking Calcium Dynamics and Immune Surveillance at the Choroid Plexus Blood-Cerebrospinal Fluid Interface. Neuron. 2020 11 25; 108(4):623-639.e10. View Abstract
59. ESTIMATION OF HP(3) AMONG STAFF MEMBERS IN TWO NUCLEAR MEDICINE UNITS IN FINLAND. Radiat Prot Dosimetry. 2020 Aug 28; 190(2):176-184. View Abstract
60. Choroid Plexus Organoids: Harnessing CSF Gatekeepers for Brain Therapeutics. Cell Stem Cell. 2020 08 06; 27(2):191-192. View Abstract
61. Cerebrospinal Fluid Magnetic Resonance Imaging: Improving Early Diagnosis of Autism and Other Neurodevelopmental Conditions. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 07; 5(7):635-637. View Abstract
62. Emergence and Developmental Roles of the Cerebrospinal Fluid System. Dev Cell. 2020 02 10; 52(3):261-275. View Abstract
63. A concerted metabolic shift in early forebrain alters the CSF proteome and depends on MYC downregulation for mitochondrial maturation. Development. 2019 10 24; 146(20). View Abstract
64. Spatiotemporal Gradient of Cortical Neuron Death Contributes to Microcephaly in Knock-In Mouse Model of Ligase 4 Syndrome. Am J Pathol. 2019 12; 189(12):2440-2449. View Abstract
65. Targeting Peripheral Somatosensory Neurons to Improve Tactile-Related Phenotypes in ASD Models. Cell. 2019 08 08; 178(4):867-886.e24. View Abstract
66. Sister, Sister: Ependymal Cells and Adult Neural Stem Cells Are Separated at Birth by Geminin Family Members. Neuron. 2019 04 17; 102(2):278-279. View Abstract
67. Superselective endovascular tissue access using trans-vessel wall technique: feasibility study for treatment applications in heart, pancreas and kidney in swine. J Intern Med. 2019 04; 285(4):398-406. View Abstract
68. Sodium Channel SCN3A (NaV1.3) Regulation of Human Cerebral Cortical Folding and Oral Motor Development. Neuron. 2018 09 05; 99(5):905-913.e7. View Abstract
69. The ESCRT-III Protein CHMP1A Mediates Secretion of Sonic Hedgehog on a Distinctive Subtype of Extracellular Vesicles. Cell Rep. 2018 07 24; 24(4):973-986.e8. View Abstract
70. Downregulation of ribosome biogenesis during early forebrain development. Elife. 2018 05 10; 7. View Abstract
71. Mice Expressing Myc in Neural Precursors Develop Choroid Plexus and Ciliary Body Tumors. Am J Pathol. 2018 06; 188(6):1334-1344. View Abstract
72. Shining new light on migraine. Sci Transl Med. 2017 07 12; 9(398). View Abstract
73. Say good night to your pain. Sci Transl Med. 2017 05 31; 9(392). View Abstract
74. ZNHIT3 is defective in PEHO syndrome, a severe encephalopathy with cerebellar granule neuron loss. Brain. 2017 05 01; 140(5):1267-1279. View Abstract
75. Filtering more than light in the developing retina. Sci Transl Med. 2017 04 19; 9(386). View Abstract
76. The brain's matchmakers. Sci Transl Med. 2017 03 08; 9(380). View Abstract
77. CSF Makes Waves in the Neural Stem Cell Niche. Cell Stem Cell. 2016 11 03; 19(5):565-566. View Abstract
78. Unverricht-Lundborg disease. Epileptic Disord. 2016 Sep 01; 18(S2):28-37. View Abstract
79. Comment on "Multiple repressive mechanisms in the hippocampus during memory formation". Science. 2016 Jul 29; 353(6298):453. View Abstract
80. Retrograde fibroblast growth factor 22 (FGF22) signaling regulates insulin-like growth factor 2 (IGF2) expression for activity-dependent synapse stabilization in the mammalian brain. Elife. 2016 04 15; 5. View Abstract
81. Sonic Hedgehog promotes proliferation of Notch-dependent monociliated choroid plexus tumour cells. Nat Cell Biol. 2016 Apr; 18(4):418-30. View Abstract
82. Progressive Differentiation and Instructive Capacities of Amniotic Fluid and Cerebrospinal Fluid Proteomes following Neural Tube Closure. Dev Cell. 2015 Dec 21; 35(6):789-802. View Abstract
83. Enlargement of choroid plexus in complex regional pain syndrome. Sci Rep. 2015 Sep 21; 5:14329. View Abstract
84. Development and functions of the choroid plexus-cerebrospinal fluid system. Nat Rev Neurosci. 2015 Aug; 16(8):445-57. View Abstract
85. Zebrafish cerebrospinal fluid mediates cell survival through a retinoid signaling pathway. Dev Neurobiol. 2016 Jan; 76(1):75-92. View Abstract
86. Spatially heterogeneous choroid plexus transcriptomes encode positional identity and contribute to regional CSF production. J Neurosci. 2015 Mar 25; 35(12):4903-16. View Abstract
87. Anti-Mullerian hormone and risk of invasive serous ovarian cancer. Cancer Causes Control. 2014 May; 25(5):583-9. View Abstract
88. The choroid plexus and cerebrospinal fluid: emerging roles in development, disease, and therapy. J Neurosci. 2013 Nov 06; 33(45):17553-9. View Abstract
89. Isolation of cerebrospinal fluid from rodent embryos for use with dissected cerebral cortical explants. J Vis Exp. 2013 Mar 11; (73):e50333. View Abstract
90. Adult neurogenesis: VCAM stems the tide. Cell Stem Cell. 2012 Aug 03; 11(2):137-8. View Abstract
91. Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron. 2012 Apr 12; 74(1):41-8. View Abstract
92. The cerebrospinal fluid: regulator of neurogenesis, behavior, and beyond. Cell Mol Life Sci. 2012 Sep; 69(17):2863-78. View Abstract
93. Dual effect of short interval between first and second birth on ductal breast cancer risk in Finland. Cancer Causes Control. 2012 Jan; 23(1):187-93. View Abstract
94. Risk of seropositivity to multiple oncogenic human papillomavirus types among human immunodeficiency virus-positive and -negative Ugandan women. J Gen Virol. 2011 Dec; 92(Pt 12):2776-2783. View Abstract
95. Neurogenesis at the brain-cerebrospinal fluid interface. Annu Rev Cell Dev Biol. 2011; 27:653-79. View Abstract
96. The cerebrospinal fluid provides a proliferative niche for neural progenitor cells. Neuron. 2011 Mar 10; 69(5):893-905. View Abstract
97. Proliferative and transcriptional identity of distinct classes of neural precursors in the mammalian olfactory epithelium. Development. 2010 Aug 01; 137(15):2471-81. View Abstract
98. The apical complex couples cell fate and cell survival to cerebral cortical development. Neuron. 2010 Apr 15; 66(1):69-84. View Abstract
99. Cystatin B deficiency sensitizes neurons to oxidative stress in progressive myoclonus epilepsy, EPM1. J Neurosci. 2009 May 06; 29(18):5910-5. View Abstract
100. Regulation of neuronal cell death by MST1-FOXO1 signaling. J Biol Chem. 2009 Apr 24; 284(17):11285-92. View Abstract
101. Demystifying MST family kinases in cell death. Curr Mol Med. 2008 Jun; 8(4):313-8. View Abstract
102. Modeling oxidative stress in the central nervous system. Curr Mol Med. 2006 Dec; 6(8):871-81. View Abstract
103. A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell. 2006 Jun 02; 125(5):987-1001. View Abstract
104. The transcription factor NFAT3 mediates neuronal survival. J Biol Chem. 2005 Jan 28; 280(4):2818-25. View Abstract
105. Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri. Eur J Cancer. 2004 May; 40(7):1058-65. View Abstract
106. Characterization of a neurotrophin signaling mechanism that mediates neuron survival in a temporally specific pattern. J Neurosci. 2003 Aug 13; 23(19):7326-36. View Abstract
107. Cdc2 phosphorylation of BAD links the cell cycle to the cell death machinery. Mol Cell. 2002 May; 9(5):1005-16. View Abstract
108. Agonists calcitonin, corticotropin-releasing hormone, and vasoactive intestinal peptide, but not prostaglandins or beta-adrenergic agonists, elevate cyclic adenosine monophosphate levels in oligodendroglial cells. J Neurosci Res. 2001 Jul 15; 65(2):165-72. View Abstract
109. Poor antibody response against human papillomavirus in adult-onset laryngeal papillomatosis. J Med Microbiol. 2001 May; 50(5):468-471. View Abstract
110. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA. 2001 Jan 03; 285(1):47-51. View Abstract
111. Prerequisites for human papillomavirus vaccine trial: results of feasibility studies. J Clin Virol. 2000 Oct; 19(1-2):25-30. View Abstract
112. Common and emerging infectious causes of hematological malignancies in the young. APMIS. 1998 Jun; 106(6):585-97. View Abstract
113. Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. BMJ. 1997 Sep 13; 315(7109):646-9. View Abstract
114. Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. J Natl Cancer Inst. 1997 Sep 03; 89(17):1293-9. View Abstract
115. Outcome for patients with leukemia, multiple myeloma and lymphoma who relapse after high dose therapy and autologous stem cell support. Leuk Lymphoma. 1996 Dec; 24(1-2):81-91. View Abstract
116. Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study. BMJ. 1996 Mar 02; 312(7030):537-9. View Abstract
117. Serum antibodies and subsequent cervical neoplasms: a prospective study with 12 years of follow-up. Am J Epidemiol. 1993 Jan 15; 137(2):166-70. View Abstract
118. Quantity of nuclear DNA in malignancies and benign lymphadenopathies associated with Epstein-Barr virus. J Clin Pathol. 1989 Jul; 42(7):699-704. View Abstract
Show All Publications Show Fewer Publications